141 related articles for article (PubMed ID: 14686928)
21. Ricin A-chain structural determinant for binding substrate analogues: a molecular dynamics simulation analysis.
Olson MA
Proteins; 1997 Jan; 27(1):80-95. PubMed ID: 9037714
[TBL] [Abstract][Full Text] [Related]
22. Analysis of several key active site residues of ricin A chain by mutagenesis and X-ray crystallography.
Kim Y; Robertus JD
Protein Eng; 1992 Dec; 5(8):775-9. PubMed ID: 1287657
[TBL] [Abstract][Full Text] [Related]
23. Free energy determinants of binding the rRNA substrate and small ligands to ricin A-chain.
Olson MA; Cuff L
Biophys J; 1999 Jan; 76(1 Pt 1):28-39. PubMed ID: 9876120
[TBL] [Abstract][Full Text] [Related]
24. Ricin toxin contains at least three galactose-binding sites located in B chain subdomains 1 alpha, 1 beta, and 2 gamma.
Frankel AE; Burbage C; Fu T; Tagge E; Chandler J; Willingham MC
Biochemistry; 1996 Nov; 35(47):14749-56. PubMed ID: 8942636
[TBL] [Abstract][Full Text] [Related]
25. The ribosomal RNA identity elements for ricin and for alpha-sarcin: mutations in the putative CG pair that closes a GAGA tetraloop.
Glück A; Endo Y; Wool IG
Nucleic Acids Res; 1994 Feb; 22(3):321-4. PubMed ID: 8127668
[TBL] [Abstract][Full Text] [Related]
26. Mutagenesis and kinetic analysis of the active site Glu177 of ricin A-chain.
Chaddock JA; Roberts LM
Protein Eng; 1993 Jun; 6(4):425-31. PubMed ID: 8332600
[TBL] [Abstract][Full Text] [Related]
27. Toxicity of ricin A chain is reduced in mammalian cells by inhibiting its interaction with the ribosome.
Jetzt AE; Li XP; Tumer NE; Cohick WS
Toxicol Appl Pharmacol; 2016 Nov; 310():120-128. PubMed ID: 27639428
[TBL] [Abstract][Full Text] [Related]
28. In vitro selection of RNA molecules that inhibit the activity of ricin A-chain.
Hesselberth JR; Miller D; Robertus J; Ellington AD
J Biol Chem; 2000 Feb; 275(7):4937-42. PubMed ID: 10671531
[TBL] [Abstract][Full Text] [Related]
29. Major structural differences between pokeweed antiviral protein and ricin A-chain do not account for their differing ribosome specificity.
Chaddock JA; Monzingo AF; Robertus JD; Lord JM; Roberts LM
Eur J Biochem; 1996 Jan; 235(1-2):159-66. PubMed ID: 8631323
[TBL] [Abstract][Full Text] [Related]
30. Structural insights into the neutralization mechanism of monoclonal antibody 6C2 against ricin.
Zhu Y; Dai J; Zhang T; Li X; Fang P; Wang H; Jiang Y; Yu X; Xia T; Niu L; Guo Y; Teng M
J Biol Chem; 2013 Aug; 288(35):25165-25172. PubMed ID: 23853097
[TBL] [Abstract][Full Text] [Related]
31. Effects of chemical modification of arginine residues outside the active site cleft of ricin A-chain on its RNA N-glycosidase activity for ribosomes.
Watanabe K; Dansako H; Asada N; Sakai M; Funatsu G
Biosci Biotechnol Biochem; 1994 Apr; 58(4):716-21. PubMed ID: 7764862
[TBL] [Abstract][Full Text] [Related]
32. Engineering a switch-on peptide to ricin A chain for increasing its specificity towards HIV-infected cells.
Au KY; Wang RR; Wong YT; Wong KB; Zheng YT; Shaw PC
Biochim Biophys Acta; 2014 Mar; 1840(3):958-63. PubMed ID: 24246953
[TBL] [Abstract][Full Text] [Related]
33. Involvement of the amino acids outside the active-site cleft in the catalysis of ricin A chain.
Kitaoka Y
Eur J Biochem; 1998 Oct; 257(1):255-62. PubMed ID: 9799127
[TBL] [Abstract][Full Text] [Related]
34. The structure and action of ricin, a cytotoxic N-glycosidase.
Robertus J
Semin Cell Biol; 1991 Feb; 2(1):23-30. PubMed ID: 1954340
[TBL] [Abstract][Full Text] [Related]
35. Site-directed mutagenesis of ricin A-chain and implications for the mechanism of action.
Ready MP; Kim Y; Robertus JD
Proteins; 1991; 10(3):270-8. PubMed ID: 1881883
[TBL] [Abstract][Full Text] [Related]
36. Peptide Mimics of the Ribosomal P Stalk Inhibit the Activity of Ricin A Chain by Preventing Ribosome Binding.
Li XP; Kahn JN; Tumer NE
Toxins (Basel); 2018 Sep; 10(9):. PubMed ID: 30217009
[TBL] [Abstract][Full Text] [Related]
37. Catalytic and cytotoxic activities of recombinant ricin A chain mutants with charged residues added at the carboxyl terminus.
Simpson JC; Roberts LM; Lord JM
Protein Expr Purif; 1995 Oct; 6(5):665-70. PubMed ID: 8535160
[TBL] [Abstract][Full Text] [Related]
38. Structure-based identification of a ricin inhibitor.
Yan X; Hollis T; Svinth M; Day P; Monzingo AF; Milne GW; Robertus JD
J Mol Biol; 1997 Mar; 266(5):1043-9. PubMed ID: 9086280
[TBL] [Abstract][Full Text] [Related]
39. A two-step binding model proposed for the electrostatic interactions of ricin a chain with ribosomes.
Li XP; Chiou JC; Remacha M; Ballesta JP; Tumer NE
Biochemistry; 2009 May; 48(18):3853-63. PubMed ID: 19292477
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of ricin A-chain (RTA) catalytic activity by a viral genome-linked protein (VPg).
Aitbakieva VR; Ahmad R; Singh S; Domashevskiy AV
Biochim Biophys Acta Proteins Proteom; 2019 Jun; 1867(6):645-653. PubMed ID: 30822539
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
